A prerequisite for understanding the molecular function of the human cytomegalovirus (HCMV) gH (UL75)-gL (UL115) complex is a detailed knowledge of the structure of this complex in its functional form, as it is present in mature virions. The gH protein is known to be a component of a 240-kDa envelope complex designated as gCIII (D. R. Gretch, B. Kari, L. Rasmussen, R. C. Gehrz, and M. F. Stinski, J. Virol. 62:875-881, 1988). However, the exact composition of the gCIII complex remains unknown. In this report, we attempted reconstitution of the gCIII complex by coexpression of gH and gL in the baculovirus expression system. Formation of recombinant gH-gL complexes of approximately 115 kDa was demonstrated; however, no highermolecular-mass (ϳ240-kDa) recombinant gH-gL complexes were detected, suggesting that the presence of gH and gL alone is not sufficient for reconstitution of the gCIII complex. To identify other mammalian and/or HCMV factors which may be necessary for gCIII formation, immunoprecipitates of gH and gL from HCMVinfected fibroblasts and purified HCMV virions were examined. This analysis did reveal a number of coprecipitating proteins which associate either transiently or integrally with gH and gL. One coprecipitating protein of 145 kDa was shown to be an integral component of gCIII, along with gH and gL. Characterization of the 145-kDa protein demonstrates that it is structurally and antigenically unrelated to gH and gL and that it appears to be virally encoded. Together, these data indicate that the 145-kDa protein is a third novel component of the mature HCMV gH-gL complex.
In all human herpesviruses studied to date, homologs of glycoprotein H (gH) and glycoprotein L (gL) have been found. These two envelope glycoproteins, which associate to form the gH-gL complex, have been implicated as key participants in fusion events critical to herpesvirus life cycles. Specifically, the gH-gL complex participates in both the pH-independent fusion of the viral envelope with the host cell plasma membrane and the cell-to-cell spread of virus (8, 10, 12, 13, 21, 24, 26, 27) . Studies of the human cytomegalovirus (HCMV) gH and gL proteins have shown that they are representative gH and gL homologs. During their cosynthesis, gH and gL interact to form a disulfide bond-dependent gH-gL complex, an association shown to be necessary for subsequent carbohydrate processing and transport of gH to the plasma membrane (7, 17, 29) ; it is currently unknown whether gL maturation is likewise dependent upon this association. Functional studies of the HCMV gH-gL complex have demonstrated that anti-idiotypic antibodies mirroring a neutralizing epitope on gH block penetration of the virus but not the initial attachment to host cells (18) . Also, these anti-idiotypic gH antibodies and other gH monoclonal antibodies have been shown to reduce plaque size, suggesting a role for the HCMV gH-gL complex in cell-to-cell spread of the virus (19, 23) . It has been postulated that the function of the HCMV gH-gL complex in the entry of HCMV is mediated through a 92.5-kDa cellular membrane protein, but whether this cellular protein acts as a receptor remains to be verified (19) . To date, however, the specific molecular mechanism by which the gH-gL complex of HCMV (or any other herpesvirus) participates in viral fusion events remains enigmatic.
In order to address the precise functionality of the HCMV gH-gL complex, it will be critical to have a definitive understanding of the structure of the functional form of this complex in mature virions. Currently, however, the composition of the gH-gL complex in the viral envelope remains unclear. Earlier studies of the HCMV envelope demonstrated that gH is a component of a 240-kDa disulfide-linked glycoprotein complex designated gCIII (7, 14, 23, 25) . Upon reduction of gCIII, gH (86 kDa) and a higher-molecular-mass species of approximately 145 kDa are seen, the latter remaining undefined (14) . It has been postulated that the 145-kDa protein may represent a modified form of the gH-gL complex (1), while others have hypothesized that this protein is a novel gene product unrelated to gH or gL (34) . Another question concerning the composition of the HCMV gCIII complex is whether gL is a constituent. Although it has been assumed that gL is part of gCIII because of its known association with gH, the presence of gL in either the gCIII complex or the virion has not been demonstrated.
We sought to reconstitute the gCIII complex by coexpression of the individual gH and gL genes in a baculovirus expression system. Although disulfide-linked recombinant gH-gL complexes were demonstrated, higher-molecular-mass forms corresponding to either a 145-kDa species or a 240-kDa gCIII complex were not observed, suggesting that expression of gH and gL alone was not sufficient to reconstitute the viral gCIII complex. To look for additional mammalian cellular and/or HCMV factors which may be necessary for formation of the gCIII complex, immunoprecipitates from HCMV-infected fibroblasts and from gradient-purified HCMV virions were analyzed. The profiles from these immunoprecipitates did demonstrate the presence of four proteins which coimmunoprecipitated with gH and gL. One of them, a 145-kDa protein, was present in both HCMV-infected cells and mature virions and associates with gH and gL to comprise the gCIII complex. Characterization of the 145-kDa protein indicates that it is structurally and antigenically unrelated to gH and gL and that it likely is the product of a viral gene. Together, these data indicate that a novel viral gene product of 145 kDa represents a third distinct member of the mature HCMV gH-gL envelope complex. (6) were cultured in Dulbecco's modified Eagle medium (DMEM; Gibco) supplemented with 5% fetal bovine serum, 0.3% glutamine (BioWhittaker), 1% PSF, and 50 g of geneticin (Gibco BRL) per ml. The AD169 strain of HCMV was grown and titered in IF cells as previously described (22) . HCMV virions were purified from clarified culture supernatants essentially as described previously (31, 32) . VTF7.3, a recombinant vaccinia virus which expresses T7 polymerase, was propagated on CV-1 cells as described previously (11) .
MATERIALS AND METHODS
Plasmids. All enzymes were from New England Biolabs. For generation of pcDNA3.gH, the gH coding sequence (amino acids 1 to 743) was amplified by PCR, using cosmid p1075 (9) containing the entire AD169 UL75 (gH) open reading frame (ORF) as a template. The sequence of the upstream primer used in this PCR, 5ЈAAGCTTGCGCAGCCGCGCTAT3Ј, corresponds to nucleotides 110145 to 110131 of AD169 plus an upstream HindIII recognition site. The sequence of the downstream primer used in this PCR, 5ЈAAGAATTCTCAGC ATGTCTTGAG3Ј, corresponds to the complement of nucleotides 107915 to 107901 of AD169 plus a downstream EcoRI recognition site. The resulting PCR product was digested with HindIII and EcoRI and subcloned into the polylinker region of pBluescript (pBs) (Stratagene). The gH coding fragment was excised from the pBs-gH plasmid by digestion with HindIII and BamHI, and the gH fragment was subcloned into HindIII-and BamHI-digested pcDNA3 (Invitrogen). For generation of pcDNA3.gL, plasmid pAcGB67B-gL-ST (see the section on construction of baculovirus vectors below) was digested with BamHI and PstI and the released gL fragment was subcloned into BamHI-and PstI-digested pBs. The resulting plasmid, pBs-gL-ST, was digested with BamHI and XhoI, and the released gL fragment was subcloned into BamHI-and XhoI-digested pcDNA3.
Construction of baculovirus transfer vectors. All enzymes were from New England Biolabs except for Amplitaq (Perkin-Elmer Express), which was used for PCR amplifications. Cosmid p1075 (9) , which contains the entire AD169 UL75 (gH) ORF, served as the template for PCR amplification of the two gH constructs. Both gH constructs utilized a common upstream sense primer. The sequence of this primer, 5ЈAGGAATTCCATGGATCTACCTTCGCAACGA 3Ј, corresponds to nucleotides 110075 to 110064 of AD169 (5) plus an upstream NcoI recognition site. For amplification of recombinant truncated gH, rgH719, the downstream primer 5ЈACATCTAGAATTCAACGACTGTCGGTGGC3Ј, which corresponds to the complement of nucleotides 107993 to 107978 of AD169, a stop codon, and a downstream EcoRI recognition site, was used. For amplification of recombinant full-length gH, gH743, the downstream primer 5ЈAAGAATTCTCAGCATGTCTTGAG3Ј, which corresponds to the complement of nucleotides 107915 to 107901 of AD169 plus a downstream EcoRI recognition site, was used. HCMV DNA was used as a template for PCR amplification of UL115 (gL). The upstream sense primer used in this PCR, 5ЈACTGGATCCATGTGCCGCCGCCCG3Ј, corresponds to nucleotides 164530 to 164516 of AD169 plus an upstream BamHI recognition site. The downstream primer for this PCR, 5ЈACTCTGCAGTTAACCACCGAACTGC GGGTGACGCCAAGCGCTGCGAGCATCCACTGC3Ј, corresponds to the complement of nucleotides 163711 to 163694 of AD169 followed by a 30-base sequence for the streptavidin affinity tag (underlined) (28), a stop codon, and a PstI recognition site. The resulting gH PCR products were digested with NcoI and EcoRI, the gL PCR product was digested with BamHI and PstI, and the digested PCR products were then gel purified. Plasmid pAcGP67B (PharMingen), which was selected as the baculovirus transfer vector, contains the Autographa californica gp67 signal peptide, which is known to be one of the most efficient signal sequences for protein translocation and secretion (30) . pAcGP67B was digested with either NcoI and EcoRI or BamHI and PstI and then gel purified. Each PCR fragment and the appropriately digested pAcGB67B were ligated overnight at 15°C with T4 DNA ligase. The ligated plasmids pAcGP67B-gH743, pAcGP67B-gH719, and pAcGP67B-gL-ST were amplified in Escherichia coli and then purified with a Qiagen Plasmid Kit. Partial DNA sequence analysis confirmed the fidelity of the PCR products.
Construction and purification of recombinant baculoviruses. Recombinant baculoviruses BV-gH743, BV-gH719, and BV-gL-ST, which, respectively, produce rgH743, rgH719, and rgL-ST (Fig. 1) , were constructed by use of a BaculoGold Transfection Kit (PharMingen) in accordance with the manufacturer's instructions. The resultant recombinant baculoviruses were subjected to three rounds of plaque purification and amplification before working viral stocks were generated. For plaque purification of recombinant baculoviruses, Tn-5 cells were infected, and at 90 min postinfection, the virus inoculum was removed. The cells were overlaid with plaquing medium (equal volumes of 1.5% CompatiGel agarose [FMC] and 2ϫ Insect X-press [BioWhittaker]) and incubated at 27°C for 5 days. For plaque amplification, plaques were picked and used to infect Tn-5 cells. At 3 days postinfection, the cell culture supernatant was subjected to plaque purification. Virus stocks were prepared by infecting Tn-5 cells at a multiplicity of infection (MOI) of 0.1 and incubating them for 4 to 5 days at 27°C. Supernatant virus was collected, titered by plaque assay as described above, and stored in light-proof containers at 4°C.
Antibodies. Antibody 6824 was raised against two gH peptides with the sequences C-SYRSFQQLKAQDSLGQQPTT and C-SDLYTPCSSSSG RRDHSLERLTR (amino acids 135 to 155 and 517 to 538, respectively, of UL75) as described previously (6) . Monoclonal antibodies AP865, which recognizes an epitope in the amino terminus of gH (34) , and 14-4b, which recognizes a conformational epitope on gH (3), were kindly provided by W. Britt. Antibody peptide RNEATRTNRAV (amino acids 196 to 206 of UL115), which was described previously (29) . Antibody 26388, kindly provided by A. Minson, is a polyclonal anti-gL serum raised against a ␤-galactosidase-gL fusion protein which contains amino acids 30 to 278 of UL115.
SDS-PAGE and immunoblotting. Protein samples to be analyzed were combined with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer (final concentration of SDS, 2%). For reduced samples, this buffer was supplemented with 4 M urea and 50 mM dithiothreitol (DTT). Resolved proteins were transferred to nitrocellulose membranes (Millipore) and probed with antibodies (outlined above) or a 1-g/ml solution of streptavidinhorseradish peroxidase (SA-HRP) (Vector Laboratories) supplemented with 2 g of avidin (Vector Laboratories) per ml. Primary antibodies were detected with HRP-conjugated goat anti-mouse and goat anti-rabbit antibodies (Pierce). Chemiluminesence (LumiGLO HRP Substrate Kit; Kirkegaard and Perry) was used to detect the peroxidase conjugates.
Endoglycosidase H digestion. Infected Tn-5 cells were lysed in a solution consisting of 1% digitonin in 150 mM NaCl, 50 mM Tris (pH 7.5), and 1 mM EDTA plus protease inhibitor cocktail (PIC) (antipain, aprotinin, chymostatin, leupeptin, and pepstatin, each at a final concentration of 2 g/ml). SDS and 2-mercaptoethanol were added to lysates to 1% and 5 mM, respectively, and the solution was incubated at 95°C for 5 min. An equal volume of 100 mM sodium citrate (pH 5.5) was added, and this mixture was supplemented with phenylmethylsulfonyl fluoride (1 mM final concentration). Each sample was split into two aliquots, one receiving 8 mU of endoglycosidase H (Boehringer Mannheim) and the other receiving an equal volume of 100 mM sodium citrate, pH 5.5. All aliquots were incubated overnight at 30°C. An additional 4 mU was then added to each of the digested samples, which were incubated for an additional 3 h.
Preparation of metabolically labeled proteins and immunoprecipitates. At 48 h postinfection, the culture medium of infected Tn-5 cells was replaced with Insect X-press without methionine (BioWhittaker) for 1 h, at which time was added 250 Ci of [ 35 35 S]methionine/ml) in methionine-and cysteine-free DMEM (Gibco) to infected fibroblasts cultures at 96 h postinfection. Culture supernatants were collected 2.5 days later, and virions were purified as described previously (22, 31) . Purified virions were lysed in RIPA buffer plus PIC for 30 min on ice and centrifuged to remove insoluble debris. Cell and viral lysates were precleared by a 1-h incubation with a nonspecific antibody followed by a 1-h incubation with immobilized protein A (Pierce) or protein G (formalin-killed cell suspension; Sigma). After preclearing was completed, bovine serum albumin was added to each sample to a final concentration of 0.5%. The precipitating antibody was then added, and after a 12-to 16-h incubation at 4°C, immobilized protein A was added for 1 h. The protein A pellets were then washed three to nine times in RIPA buffer containing 0.5% bovine serum albumin; this was followed by one wash in 150 mM NaCl-50 mM Tris-1 mM EDTA. Pellets were resuspended in SDS-PAGE sample buffer containing 2% SDS (supplemented with 4 M urea and 50 mM DTT for reduction of samples), heated at 95°C for 3 min, and subjected to SDS-PAGE. Gels were either fixed in 25% methanol-7.5% acetic acid, washed briefly in 20% methanol, and then incubated in Fluoro-Hance (Research Products International) prior to being dried and exposed to film or were dried and imaged with a GS-525 Molecular Imager (Bio-Rad).
Analysis of SDS-PAGE-resolved proteins by secondary gel electrophoresis under reducing conditions. This protocol is an adaptation of methods described by Yamashita et al. (36) . Immunoprecipitates were subjected to SDS-PAGE under nonreducing conditions, and gels were dried without fixation. Dried gels were imaged with a GS-525 Molecular Imager (Bio-Rad). The desired bands were excised from the gel and placed into the appropriate wells of the secondround SDS-polyacrylamide gel. For the second-round gel, all gel mixes contained 1 mM EDTA and the stacking gel had about twice the normal depth. The gel slices were overlaid with 2ϫ Laemmli sample buffer containing 100 mM DTT, 1.4 M ␤-mercaptoethanol, and 1 mM EDTA, and the gel was run until the gel front migrated about two-thirds the distance into the stacking gel. The power supply was then turned off, and the reduction of the samples was allowed to proceed for 30 min. The gel was then run to completion, dried, and imaged with a GS-525 Molecular Imager.
Transient coexpression of gH and gL in IF cells. Monolayers of IF cells in six-well dishes were rinsed with phosphate-buffered saline and infected with VTF7.3 (a recombinant vaccinia virus which expresses T7 polymerase) at an MOI of approximately 20, and virus was adsorbed for 1 h. After the adsorption, the infected cells were either not transfected or were cotransfected with 10 g of pcDNA3.gH and 10 g of pcDNA3.gL per well by using Lipofectin (Gibco). Both pcDNA3.gH and pcDNA3.gL contain the T7 polymerase promoter immediately upstream of the gH and gL coding sequences. At 16 h postinfection, the transfection medium was removed and methionine-deficient DMEM was added for 1 h. [ 35 S]methionine-[ 35 S]cysteine was then added at a concentration of 300 Ci of [ 35 S]methionine/ml, and cells were incubated for 3 h. The labeling medium was then removed, and the cells were rinsed, scraped, and lysed in RIPA buffer in preparation for immunoprecipitation.
RESULTS
Characterization of rgH719, rgH-743, and rgL-ST. To express the recombinant proteins (Fig. 1) , monolayer cultures of Tn-5 cells either were infected with each of the three recombinant baculoviruses (BV-gH743, BV-gH719, and BV-gL-ST) singly or were dually infected simultaneously with gH and gL baculoviruses (BV-gH743 plus BV-rgL-ST or BV-gH719 plus BV-gL-ST). Lysates of these infected insect cells were analyzed for reactivity with gH-and gL-specific antibodies in immunoblots. Lysates prepared from insect cells infected with the gH baculoviruses were immunoreactive with AP865, an anti-gH antibody ( Fig. 2A) . rgH719 and rgH743, whether expressed alone or in combination with rgL-ST, demonstrated similar patterns of immunoreactivity, consisting of a broad band and a tight, faster-migrating band. The faster-migrating bands likely represent nonglycosylated forms, based on the mobilities of these bands, which correspond well with the predicted molecular masses of rgH719 and rgH743 (79.4 and 82.3 kDa, respectively, calculated from the primary sequences). The diffuse, higher-molecular-mass bands likely represent glycosylated forms, as confirmed by subsequent endoglycosidase H treatment (Fig. 3) . Lysates from the insect cells infected with the gL baculovirus were immunoreactive with R4234, an anti-gL antibody (Fig. 2B) . The predominant immunoreactive form of 
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on November 7, 2017 by guest http://jvi.asm.org/ rgL-ST migrates at approximately 34 kDa and likely represents a glycosylated form (the predicted molecular mass of rgL-ST is 32 kDa, as calculated from the primary sequence). Since R4234, the anti-gL antibody, was known to have a high background on immunoblots, the recombinant gL was designed with a C-terminal affinity tag ( Fig. 1 ) which binds streptavidin (28) . To test the utility of the streptavidin affinity tag on rgL-ST for detection, SA-HRP was used to probe a replica of the blot shown in Fig. 2B . Figure 2C shows that the SA-HRP reacted specifically with bands which comigrated with the immunoreactive bands seen in the blot reacted with the anti-gL antibody R4234, demonstrating the utility of the affinity tag for detection of rgL-ST. Both blots probed with gL-specific reagents indicate that coexpression of rgH743 with rgL-ST resulted in decreased intracellular levels of rgL-ST relative to the levels achieved when rgL-ST was expressed alone or in combination with rgH719. One possible explanation for the reduced levels is secretion of rgL-ST; however, rgL-ST is not secreted in detectable levels from infected insect cells (data not shown). To date, a factor(s) responsible for the specific decrease in intracellular levels of rgL-ST upon coexpression with rgH743 is not known. To confirm that the recombinant proteins were glycosylated, rgH743, rgH719, and rgL-ST were digested with endoglycosidase H prior to immunoblot analysis. Endoglycosidase H treatment resulted in a shift of the electrophoretic mobility of the recombinant proteins, demonstrating that rgH719, rgH743, and rgL-ST contain N-linked glycans, predominantly of the high-mannose form (Fig. 3) . The identities of the multiple species seen in the rgL-ST blot are not known. These species could be the consequence of incomplete digestion. Alternatively, the rgL-ST may contain other modifications, such as O-linked oligosaccharides; this has been shown for the pseudorabies virus glycoprotein 50 expressed in the baculovirus expression system (33) . The mobility shifts of rgH719 and rgH743 showed the loss of approximately 8 kDa, or four Nlinked carbohydrate chains, which is consistent with the number of N-linked chains found on HCMV-derived gH (1). The digested rgL-ST showed a shift of approximately 2 kDa, indicating the utilization of the single N-glycosylation site, also consistent with findings of HCMV-derived gL (17, 29) . Although the recombinant proteins contain predominantly highmannose N-linked glycans, which is in contrast to the complexform N-linked glycans found on native gH and gL (1, 17, 29) , the presence of the high-mannose N-linked glycans on the recombinant proteins is likely a consequence of their expression in the baculovirus system. Assessment of formation of recombinant gH-gL complexes. To determine whether rgH719 and rgH743 could specifically interact with rgL-ST to form recombinant gH-gL complexes, we examined whether rgL-ST was able to coimmunoprecipitate with rgH743 and rgH719 in dually infected insect cells. As shown in Fig. 4A , immunoprecipitations of the dually infected insect cell lysates with AP865, an anti-gH antibody, revealed the coimmunoprecipitation of rgL-ST with rgH743, the fulllength form of gH. Additionally, rgL-ST coimmunoprecipi- FIG. 3 . Endoglycosidase H digestion of rgH719, rgH743, and rgL-ST. Mock-infected (M) and infected Tn-5 cell lysates were digested with endoglycosidase H as described in Materials and Methods. Protein samples were analyzed by SDS-PAGE (gH, 10% polyacrylamide; gL, 12% polyacrylamide), under reducing conditions, electroblotted, and probed with antibody (AP865, an anti-gH antibody, and SA-HRP, respectively). tated with the truncated form of gH, rgH719, indicating that the transmembrane and cytoplasmic domains are not necessary for complex formation. The coimmunoprecipitation of rgL-ST with rgH743 and rgH719 appeared to be specific, since a recombinant form of HCMV gB, gB-S (4), did not coimmunoprecipitate with rgH743 or rgH719 when coexpressed (Fig.  4A) . Expression of gB-S in this experiment was confirmed by immunoprecipitation of gB-S with an anti-gB antibody (data not shown). To determine whether the recombinant gH-gL complexes were disulfide bond dependent and whether any higher-molecular-mass forms of the complex were present in the dually infected insect cells, immunoblot analysis of infected insect cell lysates was performed under nonreducing conditions. Under these conditions, an anti-gH antibody detected an approximately 115-kDa protein in lysates from insect cells dually infected with BV-gH743 and BV-gL-ST (Fig. 4B) . The size of this protein is consistent with the sum of the sizes of rgH743 and rgL-ST. A faint band migrating slightly faster than the 115-kDa protein was also observed in lysates containing rgH719 and rgL-ST and likely represents the rgH719-rgL-ST complex. The apparent lower abundance of the rgH719-rgL-ST complex is likely due to the secretion of rgH719 (data not shown). However, no higher-molecular-mass forms of the recombinant gH-gL complex, such as a 145-or 240-kDa species, were detected under these or any other experimental conditions. Collectively, these data demonstrate that coexpression of recombinant gH and gL leads to formation of disulfide bond-dependent recombinant gH-gL complexes but that gH Immunoprecipitation of gH and gL from HCMV-infected cells and purified virions. To look for mammalian cellular and/or HCMV factors which may be necessary for reconstitution of the gCIII complex, immunoprecipitates of HCMVinfected fibroblasts with anti-gH and -gL antibodies were performed and the resultant precipitates were examined. When these immunoprecipitates were analyzed under nonreducing conditions (Fig. 5A) , monomer gH (86 kDa) was detected with anti-gH antibodies and, to a lesser degree, with the anti-gL antibody. Monomer gL was not detected due to the resolution capability of the gel system. A Ͼ200-kDa protein, likely representing the intact gCIII complex, was immunoprecipitated with antibody 14-4b, which was raised against native gCIII; this Ͼ200-kDa protein was immunoprecipitated less efficiently with anti-gH antibody AP865 and anti-gL antibody 26388, which were raised against prokaryotically expressed gH and gL, respectively (see Materials and Methods). It may be possible that the epitopes with which antibodies AP865 and 26388 react are masked or inaccessible when gH and gL are in the gCIII complex. Two coprecipitating proteins of 145 and 115 kDa were also observed under nonreducing conditions. Interestingly, the 145-kDa protein was seen predominantly in immunoprecipitates with anti-gH antibody AP865 and with anti-gL antibody 26388 and not in immunoprecipitates with the anti-gH antibody 14-4b. This is in contrast to the immunoprecipitation pattern of the Ͼ200-kDa gCIII complex. Figure 5B shows a profile of these immunoprecipitates analyzed under reducing conditions. Under these conditions, the Ͼ200-kDa gCIII complex was no longer apparent and the presence of the 115-kDa protein was likewise greatly decreased. Monomeric gH and gL (now detectable at 34 kDa) were readily detectable. The 145-kDa coprecipitating protein was also seen under reducing conditions. In addition, two proteins of approximately 55 and 65 kDa were also specifically recovered in the immunoprecipitate. To determine if any of these coprecipitating proteins were also present in virions, immunoprecipitations of gradient-purified HCMV virions were performed and the resultant immunoprecipitates were analyzed under reducing conditions (Fig. 5C ). This immunoprecipitation revealed that the 145-and 65-kDa coprecipitating proteins were present in virions. Additionally, gL was immunoprecipitated from virions; this is the first demonstration of gL in the HCMV virion.
Treatment of the >200-, 145-, and 115-kDa coprecipitating proteins with reducing agents. To ascertain the composition of the Ͼ200-kDa gCIII complex and of the 145-and 115-kDa coprecipitating proteins, these three species were isolated from nonreduced immunoprecipitates and subjected to treatment with reducing agents and subsequent SDS-PAGE. As shown in Fig. 6A , reduction of the Ͼ200-kDa complex showed that it is composed of three protein species of 145, 86, and 34 kDa. Figure 6B shows that the 115-kDa protein was reduced to 86-and 34-kDa proteins which comigrated with authentic gH and gL. In contrast, the mobility of the 145-kDa protein was not affected by this treatment with reducing agents (Fig. 6B) , indicating that it does not represent a disulfide-dependent complex of gH and gL.
Antigenic analysis of the 145-kDa protein.
To determine if the 145-kDa protein is antigenically related to gH or gL, HCMV virions were immunoblotted with anti-gH and -gL antibodies. We took advantage of anti-gH antibody 6824, which was produced against two 20-amino-acid peptides derived from gH, and anti-gL antibody 26388, which was raised against a prokaryotically expressed gL fusion protein. These two antibodies will detect the presence of the gH and gL sequences, respectively, in contrast to monoclonal antibodies such as 14-4b, which recognize conformation-dependent epitopes. As shown in Fig. 7 , neither the anti-gH nor the anti-gL antibody reacted with the 145-kDa protein. The 145-kDa protein is not evident after longer exposure times (up to 15 min) (data not shown). These data strongly argue in favor of the hypothesis that the 145-kDa protein is antigenically distinct from gH and gL. FIG. 6 . Treatment of the Ͼ200-, 145-, and 115-kDa coprecipitating proteins with reducing agents. Metabolically labeled infected cell lysates were immunoprecipitated with anti-gH or -gL antibodies, and immunoprecipitates were subjected to SDS-PAGE (6% and 10% polyacrylamide gels, respectively) under reducing and nonreducing conditions, respectively. After the dried gel were imaged, the Ͼ200-, 145-, and 115-kDa proteins were excised from the nonreduced gels and subjected to subsequent SDS-10% PAGE in the presence of DTT and ␤-mercaptoethanol. The corresponding autoradiograms reduction of the Ͼ200-kDa protein show reduction of the 115-and 145-kDa proteins (gH and gL were also excised from immunoprecipitates and run as standards) show (A) and (B).
FIG. 7.
Antigenic analysis of the 145-kDa coprecipitating protein. Gradientpurified virions were subjected to SDS-10% PAGE under nonreducing conditions, electroblotted, and probed with the gH antipeptide antibody 6824 and the gL antipeptide antibody 26388. Immunoreactive bands were visualized by chemiluminescence; the blot was exposed to film for 1 min.
Immunoprecipitation of gH and gL coexpressed in IF cells.
To determine whether the 145-kDa protein is a cellular protein present in fibroblast cells or an HCMV gene product, gH and gL were transiently coexpressed in IF cells in the absence of other HCMV viral factors. To coexpress gH and gL, IF cells were infected with recombinant vaccinia virus VTF7.3, which expresses T7 polymerase, and subsequently cotransfected with plasmids containing the gH and gL coding sequences under the control of the T7 promoter. As shown in Fig. 8 , an anti-gH antibody coimmunoprecipitated gH and gL but not the 145-kDa protein, strongly suggesting that the 145-kDa protein is the product of an HCMV ORF.
DISCUSSION
The HCMV gH-gL complex plays a critical role in the life cycle of HCMV, most likely by facilitating the viral fusion machinery. Yet the specific molecular mechanism by which this or any other herpesvirus gH-gL complex acts in the viral fusion events remains enigmatic. As a prerequisite to elucidating how the HCMV gH-gL complex participates in fusion events, it will be necessary to have a definitive understanding of the structure of this complex in its functional form, as it exists in the HCMV envelope. The gH protein is known to be part of a highmolecular-mass envelope complex isolated from the HCMV virion (7, 14, 23, 25) , but this 240-kDa complex, known as gCIII, has remained largely uncharacterized.
Our analysis has demonstrated that the gCIII complex cannot be reconstituted by coexpression of gH and gL in the baculovirus system. This suggests that formation of the gCIII complex requires the presence of specific mammalian and/or HCMV factors. We have found evidence of at least three proteins, of 145, 65, and 55 kDa, which associate with gH and gL in HCMV-infected cells and in virions. The identities of the 65-and 55-kDa coprecipitating proteins have not yet been determined. However, on the basis of their profiles (Table 1) , we have been able to postulate their identities. The 65-kDa protein, which is present in lysates and virions, may represent the abundant pp65 tegument protein. Indeed, it is plausible to speculate that such an association between matrix protein pp65 and the cytoplasmic tail of the gCIII complex may be required, for instance, in the maturation of HCMV during egress. Alternatively, this 65-kDa protein could be the 65-kDa glycoprotein known to be present in HCMV virions (2) . The 55-kDa protein was detected only in infected cells and thus may represent a host cell protein. Interestingly, this 55-kDa protein does not coprecipitate in immunoprecipitations utilizing antibody 14-4b (Fig. 5B) , which recognizes gH only in a conformation-dependent manner, suggesting that the 55-kDa protein may be a chaperone which associates with gH as the latter folds. Coincidentally, the size of this 55-kDa protein is similar to that of a known endoplasmic reticulum resident, protein disulfide isomerase (55 to 60 kDa), which is known to associate with nascent proteins which require disulfide bonds for proper folding and conformation (15, 16, 35) . Studies to ascertain the true identities of the 65-and 55-kDa proteins are under way.
The 145-kDa coprecipitating protein has an intriguing profile which indicates that it associates with gH and gL as a third novel member of the gCIII complex (Table 1) . Our inability to reconstitute the gCIII complex in the baculovirus system and in transfected fibroblasts suggested that the 145-kDa protein did not represent a modified form of gH or gL. We further characterized the 145-kDa protein and confirmed that it was struc- turally and antigenically distinct from gH and gL. The 145-kDa protein appears to be a viral gene product, since a 145-kDa protein did not coprecipitate with gH and gL when coexpressed in fibroblast cells (Fig. 8) . It is possible that the 145-kDa protein is a cellular protein which is upregulated upon HCMV infection. However, given the large number of ORFs encoded by HCMV, it is highly likely that the 145-kDa protein is a viral gene product. Confirmation of the identity of the 145-kDa protein will require microsequencing of the protein, which is currently under way in our laboratory. Based on these data, we conclude that the HCMV gH-gL complex, as present in the HCMV envelope, is composed of gH, gL, and a 145-kDa protein which is a novel HCMV gene product unrelated to gH or gL. This finding of a third component of the HCMV gH-gL complex mirrors recent findings for the Epstein-Barr virus gH-gL complex, which also associates with a third viral gene product, gp42 (20) . Interestingly, it has been shown that this third component of the Epstein-Barr virus gH-gL complex is needed for entry of the virus into B cells but not for their entry into epithelial cells (20) . Whether the 145-kDa protein functions similarly in HCMV, which has been found to be associated with a diverse number of human cell types, remains to be determined. However, once we have identified and cloned the 145-kDa gene product, it will be possible to begin addressing the specific molecular functions of the HCMV gH-gL-145-kDa protein complex in the viral life cycle.
